http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004005286-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f46ae8a522d204f38a338161d0294316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9802c244407d5ef970e0b8e1ea210cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1a08534f8c520df857c95a19be741b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27b2a75cdbc38969b2ca2a4b2ef26fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea1de638d3a780a4caedab23e78f0c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b3624883c5aad6d32d4279828d52ac0
publicationDate 2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004005286-A3
titleOfInvention Viral inhibitors
abstract The present invention relates to a pharmaceutical composition for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine derivative having the general formula (Z): (formula). The invention also relates to processes for the preparation of compounds according to the invention having above mentioned general formula and their use as a medicine or to treat or prevent viral infections.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9290450-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076365-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7888363-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359379-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7803944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893084-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7737162-B2
priorityDate 2002-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0344414-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5302601-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9516687-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9611192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2158440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9927929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9612703-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226448050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425153719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9227

Total number of triples: 52.